Healius Limited (ASX:HLS)
Australia flag Australia · Delayed Price · Currency is AUD
0.7550
-0.0150 (-1.95%)
Aug 1, 2025, 4:11 PM AEST

Healius Company Description

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia.

The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services.

The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands.

It operates medical laboratories, medical centers, patient collection centers, and community imaging centers.

The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018.

Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Healius Limited
CountryAustralia
Founded1994
IndustryDiagnostics & Research
SectorHealthcare
Employees9,658
CEOPaul Anderson

Contact Details

Address:
161 Castlereagh Street
Sydney, Victoria 2000
Australia
Phone61 2 9432 9400
Websitehealius.com.au

Stock Details

Ticker SymbolHLS
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000033359
SIC Code8011

Key Executives

NamePosition
Paul D. Anderson B.Com., C.A.MD, Chief Executive Officer and Director
Stephen Humphries B.Sc.Chief Financial Officer& Company Secretary
Dr. Jan Van RooyenHead and Group Executive of Healius Pathology
Paula BaylissGroup Executive of People and Culture
John McKechnieAdvisor
Dr. Phil LucasChief Executive of Lumus Imaging
Ian McphanChief Operating Officer of Healius Pathology
Sharon NgHead of Group FP&A
Arjun NarangGroup Executive of Operations
Jon EideGroup Executive of Commercial and Customer